These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11021117)

  • 21. [The history of glaucoma (author's transl)].
    François J
    Klin Monbl Augenheilkd; 1977 Dec; 171(6):832-6. PubMed ID: 342809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endothelins and nitric oxide: their significance in the regulation of ocular blood flow and intraocular pressure and their role in the pathogenesis of primary glaucoma].
    Bakshinskiĭ PP
    Vestn Oftalmol; 1999; 115(3):33-7. PubMed ID: 10432853
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma.
    Zhou Y; Pernet V; Hauswirth WW; Di Polo A
    Mol Ther; 2005 Sep; 12(3):402-12. PubMed ID: 15975850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat.
    Martin KR; Levkovitch-Verbin H; Valenta D; Baumrind L; Pease ME; Quigley HA
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2236-43. PubMed ID: 12091422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there more to glaucoma treatment than lowering IOP?
    Mozaffarieh M; Flammer J
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S174-9. PubMed ID: 17998043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical changes and treatment in glaucoma.
    Ciotu IM; Stoian I; Gaman L; Popescu MV; Atanasiu V
    J Med Life; 2015; 8(1):28-31. PubMed ID: 25914734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Harizman N; Valenta DF; Pease ME; Melamed S
    Exp Eye Res; 2005 May; 80(5):663-70. PubMed ID: 15862173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential value of natural antioxidative treatment in glaucoma.
    Mozaffarieh M; Grieshaber MC; Orgül S; Flammer J
    Surv Ophthalmol; 2008; 53(5):479-505. PubMed ID: 18929760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the present pathogenetic concept of glaucomatous optic neuropathy?
    Flammer J; Mozaffarieh M
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S162-73. PubMed ID: 17998042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical approach to normal intraocular pressure glaucoma].
    Cerovski B; Popović Suić S; Bujger Z; Miljenka T; Cerovski J
    Acta Med Croatica; 2005; 59(2):123-8. PubMed ID: 15909886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target intraocular pressure in the management of glaucoma.
    Popović-Suić S; Sikić J; Vukojević N; Cerovski B; Nasić M; Pokupec R
    Coll Antropol; 2005; 29 Suppl 1():149-51. PubMed ID: 16193700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exercise on intraocular pressure and ocular blood flow: a review.
    Risner D; Ehrlich R; Kheradiya NS; Siesky B; McCranor L; Harris A
    J Glaucoma; 2009 Aug; 18(6):429-36. PubMed ID: 19680049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide as a mediator of glaucoma pathogenesis.
    Sacca S
    Med Sci Monit; 2002 Aug; 8(8):LE33-34. PubMed ID: 12233710
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tendencies in the etiopathogenesis of glaucoma--present and future].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(3):10-22. PubMed ID: 19149112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock proteins, immunity and glaucoma.
    Tezel G; Yang J; Wax MB
    Brain Res Bull; 2004 Feb; 62(6):473-80. PubMed ID: 15036560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.
    Iwabe S; Moreno-Mendoza NA; Trigo-Tavera F; Crowder C; García-Sánchez GA
    Vet Ophthalmol; 2007; 10 Suppl 1():12-9. PubMed ID: 17973830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The future started: nitric oxide in glaucoma].
    Stefan C; Dumitrica DM; Ardeleanu C
    Oftalmologia; 2007; 51(4):89-94. PubMed ID: 18543682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.